Elicio Therapeutics's market cap is currently ―. The company's EPS TTM is $-6.148; its P/E ratio is -1.47; Elicio Therapeutics is scheduled to report earnings on March 29, 2024, and the estimated EPS forecast is $-1.03. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -10.66M	$ -6.84M	$ -4.68M	$ -6.84M	$ -6.25M
EBITDA	$ -10.39M	-	$ -4.64M	$ -6.58M	$ -5.96M
Net Income Common Stockholders	$ -10.66M	$ -7.56M	$ -4.54M	$ -6.44M	$ -8.99M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 14.84M	$ 21.68M	$ 29.20M	$ 50.50M	$ 55.14M
Total Assets	$ 30.99M	$ 37.62M	$ 41.75M	$ 52.79M	$ 61.32M
Total Debt	$ 7.15M	$ 7.40M	$ 297.00K	$ 3.71M	$ 3.96M
Net Debt	$ -7.69M	$ -14.28M	$ -28.90M	$ -46.79M	$ -51.19M
Total Liabilities	$ 17.70M	$ 14.06M	$ 2.10M	$ 9.02M	$ 11.11M
Stockholders Equity	$ 13.29M	$ 23.56M	$ 39.65M	$ 43.77M	$ 50.21M
Cash Flow	-
Free Cash Flow	$ -5.23M	-	$ -8.03M	$ -4.43M	$ -8.41M
Operating Cash Flow	$ -5.18M	$ -9.54M	$ -8.03M	$ -4.43M	$ -8.41M
Investing Cash Flow	$ -45.00K	$ 10.01M	$ -10.00M	-	$ 0.00
Financing Cash Flow	$ 59.00K	$ 34.82M	$ -3.27M	$ -15.00K	$ -17.00K

Currency in USD

Elicio Therapeutics Earnings and Revenue History

Income Statement >

Elicio Therapeutics Debt to Assets

Balance Sheet >

Elicio Therapeutics Cash Flow

Cash Flow >

Elicio Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing